Glioblastoma is the most prevalent and lethal primary intrinsic
brain tumor.
Glioblastoma displays hierarchical arrangement with a population of self-renewing and tumorigenic
glioma tumor initiating cells (
TICs), or cancer stem cells. While non-neoplastic neural stem cells are generally quiescent,
glioblastoma TICs are often proliferative with mitotic control offering a potential point of fragility. Here, we interrogate the role of cell-division cycle
protein 20 (CDC20), an essential activator of
anaphase-promoting complex (APC) E3 ubiquitination
ligase, in the maintenance of
TICs. By
chromatin analysis and immunoblotting, CDC20 was preferentially expressed in
TICs relative to matched non-
TICs. Targeting CDC20 expression by RNA interference attenuated
TIC proliferation, self-renewal and in vivo
tumor growth. CDC20 disruption mediated its effects through induction of apoptosis and inhibition of cell cycle progression. CDC20 maintains
TICs through degradation of p21CIP1/WAF1, a critical negative regulator of
TICs. Inhibiting CDC20 stabilized p21CIP1/WAF1, resulting in repression of several genes critical to
tumor growth and survival, including CDC25C, c-Myc and
Survivin. Transcriptional control of CDC20 is mediated by FOXM1, a central
transcription factor in
TICs. These results suggest CDC20 is a critical regulator of
TIC proliferation and survival, linking two key
TIC nodes-FOXM1 and p21CIP1/WAF1-elucidating a potential point for therapeutic intervention.